Sort   by:  
 Page size 
UnknownParakinesia Brachialis Oscitans in a Patient With a First Manifestation of Multiple Sclerosis.
Not available
S-EPMC10629275 | biostudies-literature
UnknownInnate generation of thrombin and intracellular oxidants in airway epithelium by allergen Der p 1.
Not available
S-EPMC5052125 | biostudies-literature
UnknownDisease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosis.
Not available
S-EPMC10638874 | biostudies-literature
UnknownDid it hurt? COVID-19 vaccination experience in people with multiple sclerosis.
Not available
S-EPMC9250705 | biostudies-literature
UnknownEffects of cladribine on intrathecal and peripheral B and plasma cells.
Not available
S-EPMC11748000 | biostudies-literature
UnknownNeuropsychological evaluation and rehabilitation in multiple sclerosis (NEuRoMS): protocol for a mixed-methods, multicentre feasibility randomised controlled trial.
Not available
S-EPMC9187894 | biostudies-literature
UnknownDexamethasone in Hospitalized Patients with Covid-19.
Not available
S-EPMC7383595 | biostudies-literature
UnknownSubcutaneous cladribine to treat multiple sclerosis: experience in 208 patients.
Not available
S-EPMC8842147 | biostudies-literature
UnknownAzithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
Sort   by:  
 Page size